suggestion box…. nitric oxide anyone ??
After
Bayer donated 3 million chloroquine tablets on Thursday, Mylan and Teva unveiled their own initiatives to make the malaria drug more readily available.
Mylan is
ramping up production of hydroxychloroquine and
Teva announced a donation of 16 million tablets. Mylan believes it can produce 50 million tablets in the coming month. The drug isn't approved to treat COVID-19 but has shown promise, and the FDA is opening up access to it
Israel is allowing generics to
AbbVie's patent-protected
Kaletra to be imported into the country to treat COVID-19 patients,
according to reports. The move comes amid calls to limit prices on eventual coronavirus vaccines and treatments—and after the drug stumbled in a trial in COVID-19 patients, though one analyst saw
rays of hope in those data.
The
FDA on Friday
granted Bellerophon an emergency expanded access for its proprietary inhaled nitric oxide, INOpulse, to treat COVID-19 patients. The company's shares were trading sharply up Friday morning before the markets opened